KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Amortizatization of Intangibles (2018 - 2025)

Adaptive Biotechnologies' Amortizatization of Intangibles history spans 8 years, with the latest figure at $376000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 94.58% year-over-year to $376000.0; the TTM value through Dec 2025 reached $2.5 million, down 69.4%, while the annual FY2025 figure was $2.5 million, 69.4% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $376000.0 at Adaptive Biotechnologies, down from $428000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $6.9 million in Q4 2024 and bottomed at -$8.5 million in Q4 2021.
  • The 5-year median for Amortizatization of Intangibles is $425500.0 (2021), against an average of $201700.0.
  • The largest annual shift saw Amortizatization of Intangibles tumbled 1678.35% in 2021 before it surged 1516.08% in 2024.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$8.5 million in 2021, then skyrocketed by 141.44% to $3.5 million in 2022, then crashed by 87.83% to $429000.0 in 2023, then soared by 1516.08% to $6.9 million in 2024, then tumbled by 94.58% to $376000.0 in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Amortizatization of Intangibles are $376000.0 (Q4 2025), $428000.0 (Q3 2025), and $1.3 million (Q2 2025).